GET DAILY SIGNALSCarpenter Technology (CRS) Stock Slips -16.7% Over 30 Days Despite Record Earnings
Key Takeaways
- Carpenter Technology (CRS) shares fell roughly 16.7% over the last 30 days, declining from about $570 to near $475.
- The pullback occurred despite record fourth-quarter fiscal 2026 results, including adjusted EPS of $3.23 and record operating income of $206.9 million.
- A sudden leadership transition — the passing of newly appointed CEO Brian Malloy and the reappointment of Tony Thene — added near-term uncertainty.
- Mixed analyst actions, insider selling, and profit-taking after a strong run pressured sentiment.
- Longer-term demand drivers, including a strengthening aerospace and defense market, remain intact, supported by fiscal 2027 operating income guidance of $850–$880 million.
Company Overview and Market Position
Carpenter Technology Corporation is a leading producer of high-performance specialty alloy materials and process solutions for critical applications across aerospace and defense, medical, energy, transportation, and industrial and consumer markets. The company operates through two primary segments: Specialty Alloys Operations (SAO), its largest business, and Performance Engineered Products (PEP).
CRS supplies specialty alloys, titanium, and powder metals used in demanding environments such as jet engines, aircraft fasteners and structural components, medical devices, and energy equipment. Investors follow the stock closely because of its leverage to aerospace build rates and defense demand, its expanding operating margins, and a multi-year brownfield expansion project designed to support future earnings growth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, CRS declined approximately 16.7%, falling from a close near $570 to roughly $475. The move lower was sharp but not linear: the stock dropped notably around its late-July earnings report and continued grinding lower through August before stabilizing near the $465–$475 range in early September.
The quarterly picture is different. Over the last quarter, CRS is little changed — down roughly 2% from early June — but the path has been highly volatile. Shares rallied into early July to a 52-week high near $626 before a sharp correction erased those gains and brought the stock back to levels last seen in June. The contrast between the modest quarterly change and the steep 30-day decline highlights how much of the recent weakness has been concentrated in the past several weeks.
What Drove the Recent Decline
The recent decline came despite a strong earnings report. On July 30, 2026, Carpenter Technology reported fourth-quarter fiscal 2026 adjusted earnings of $3.23 per share, beating consensus estimates, on net sales of $851.0 million, up 12.6% year over year. Operating income reached a record $206.9 million, with the SAO segment posting a record 37.8% adjusted operating margin.
However, the same period brought a significant leadership disruption: newly appointed CEO Brian Malloy passed away shortly after assuming the role, and Executive Chairman Tony Thene was reappointed as CEO. Management's guidance was also overshadowed by concerns, and several sell-side actions were mixed — including price-target reductions and a downgrade from at least one firm, even as others raised targets. Notable insider selling, including a large sale by the CEO over the prior 90 days, added to the cautious tone. From what I see, the combination of executive-transition uncertainty, profit-taking following a strong run, mixed analyst sentiment, and insider selling outweighed the fundamental earnings strength in the near term.
Quarterly Performance Context
Over the last quarter, CRS followed a broader narrative of a powerful aerospace-led rally that gave way to consolidation. Early in the period, shares climbed on accelerating aerospace and defense demand, rising production rates at major aircraft manufacturers, and record profitability, reaching a 52-week high near $626 in early July.
The subsequent pullback reflected a combination of factors: the unexpected CEO transition, profit-taking after the stock's rapid appreciation, and a rotation in sentiment around specialty-materials names. Despite the equity-market weakness, the underlying operating story stayed strong — fiscal 2026 revenue rose to $3.12 billion, full-year adjusted EPS reached $10.76, and management guided fiscal 2027 operating income to $850–$880 million, implying 21%–25% growth. The quarter ultimately illustrates strong fundamentals coexisting with near-term equity-market volatility.
Key Factors to Watch Going Forward
Looking ahead, investors will monitor several key factors for CRS. First, execution against the fiscal 2027 operating income guidance of $850–$880 million and the timing of the brownfield expansion, which management expects to contribute incremental operating income beginning in fiscal 2028. Second, aerospace and defense build rates and order flow, given the company's exposure to aircraft production and maintenance demand.
Third, margin trends in the SAO segment after 18 consecutive quarters of expansion, and any recovery in the medical and energy end markets, which posted year-over-year declines. Fourth, the leadership transition under reappointed CEO Tony Thene and any further insider or institutional activity. Finally, broader macro conditions, including industrial demand, interest rates, and sector rotation within materials and aerospace equities, will influence sentiment. These are factors to monitor rather than a basis for any specific investment prediction. I’m watching this closely as the story develops.
Exploring Systematic Trading Approaches
In my own analysis, I sometimes look at automated strategies to help contextualize moves like the one in CRS. Tickeron’s AI Trading Bots offer a range of algorithmic approaches that trade various tickers, and reviewing their performance metrics can provide additional perspective on how different risk profiles align with current market conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CRS in -3.28% downward trend, sliding for three consecutive days on October 28, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CRS declined for three days, in 192 of 255 cases, the price declined further within the following month. The odds of a continued downward trend are 75%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CRS turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 26 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
The Aroon Indicator for CRS entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRS advanced for three days, in 281 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
CRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CRS's P/B Ratio (6.298) is slightly higher than the industry average of (3.033). P/E Ratio (26.731) is within average values for comparable stocks, (8.852). Projected Growth (PEG Ratio) (1.380) is also within normal values, averaging (0.744). Dividend Yield (0.003) settles around the average of (0.029) among similar stocks. P/S Ratio (6.645) is also within normal values, averaging (6248.204).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. CRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of specialty metals
Industry MetalFabrication
Advertisement